U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Consolidated Guidelines on HIV Testing Services: 5Cs: Consent, Confidentiality, Counselling, Correct Results and Connection 2015. Geneva: World Health Organization; 2015 Jul.

Cover of Consolidated Guidelines on HIV Testing Services

Consolidated Guidelines on HIV Testing Services: 5Cs: Consent, Confidentiality, Counselling, Correct Results and Connection 2015.

Show details

REFERENCES

1.
Rosenberg NE, Pilcher CD, Busch MP, Cohen MS. How can we better identify early HIV infections? Curr Opin HIV AIDS. 2015;10(1):61–8. [PMC free article: PMC4490585] [PubMed: 25389806]
2.
Diagnosis of HIV infection in infants and children: WHO recommendations. Geneva: World Health Organization; 2010. [1 April 2015]. http://www​.who.int/hiv​/pub/paediatric/diagnosis/en/
3.
Suthar A, Ford N, Bachanas P, Wong V, Rajan J, Saltzman A, et al. Towards universal voluntary HIV testing and counselling: a systematic review and meta-analysis of community-based approaches. PLoS Med. 2013;10(8):e1001496. [PMC free article: PMC3742447] [PubMed: 23966838]
4.
Sullivan AK, Raben D, Reekie J, Rayment M, Mocroft A, Esser S, et al. Feasibility and effectiveness of indicator condition-guided testing for HIV: results from HIDES I (HIV indicator diseases across Europe study). PLoS One. 2013;8(1):e52845. [PMC free article: PMC3546115] [PubMed: 23341910]
5.
Study Group 1 of the Global Harmonization Task Force. Definition of the terms ‘medical device’ and ‘in vitro diagnostic (IVD) medical device’. Global Harmonization Task Force; 2012. [25 June 2015]. http://www​.imdrf.org​/docs/ghtf/final/sg1​/technical-docs/ghtf-sg1-n071-2012-definition-of-terms-120516.pdf.
6.
Optimizing health worker roles to improve access to key maternal and newborn health interventions through task-shifting. Geneva: World Health Organization; 2014. [17 March 2015]. http://apps​.who.int/iris​/bitstream/10665​/77764/1/9789241504843_eng.pdf. [PubMed: 23844452]
7.
Multi-analyte testing for HIV and other infections; UN meeting with manufacturers; 23-25 Sept 2013; Geneva. World Health Organization; 2013. [13 March 2015]. http://apps​.who.int/prequal​/trainingresources​/pq_pres/meeting​_WHO_UNICEF_UNFPA_2013​/Day_3/32_Vercauteren.pdf.
8.
Guidelines for using HIV testing technologies in surveillance: selection, evaluation and implementation. Geneva: World Health Organization, Joint United Nations Programme on HIV/AIDS; 2009. [2 April 2015]. http://data​.unaids.org​/Publications/IRC-pub02​/jc602-hivsurvguidel_en.pdf.
9.
HIV assays operational characteristics: HIV rapid diagnostic tests (detection of HIV-1/2 antibodies): report 17. Geneva: World Health Organization; 2013. [9 March 2015]. http://apps​.who.int/iris​/bitstream/10665​/93679/1/9789241506472_eng.pdf?ua=1.
10.
Consolidated guidelines on HIV diagnosis, prevention and treatment among key populations. Geneva: World Health Organization; 2014. [14 March 2015]. http://apps​.who.int/iris​/bitstream/10665​/128048/1/9789241507431_eng​.pdf?ua=1&ua=1.
11.
A handbook for improving testing and counselling services – field test version. Geneva: World Health Organization; 2010. [22 May 2015]. http://www​.who.int/hiv​/pub/vct/9789241500463/en/
12.
Delivering HIV test results and messages for re-testing and counselling in adults. Geneva: World Health Organization; 2010. [22 May 2015]. http://www​.who.int/hiv​/pub/vct/hiv_re_testing/en/ [PubMed: 26269878]
13.
Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Geneva: World Health Organization; 2013. [22 May 2015]. http://www​.who.int/hiv​/pub/guidelines/arv2013/en/ [PubMed: 24716260]
14.
March 2014 supplement to the consolidated HIV guidelines on the use of antiretroviral therapy: recommendations for a public health approach. Geneva: World Health Organization; 2014. [22 May 2015]. http://www​.who.int/hiv​/pub/guidelines/arv2013​/arvs2013upplement_march2014/en/
15.
Methodology - understanding the HIV estimates. Geneva: Joint United Nations Programme on HIV/AIDS; 2013. [26 May 2015]. http://www​.unaids.org​/sites/default/files​/en/media/unaids/contentassets​/documents​/epidemiology/2013/gr2013​/20131118_Methodology.pdf.
16.
Guidance on couples HIV testing and counselling including antiretroviral therapy for treatment and prevention in serodiscordant couples: recommendations for a public health approach. Geneva: World Health Organization; 2012. [22 May 2015]. http://www​.who.int/hiv​/pub/guidelines/9789241501972/en/ [PubMed: 23700649]
17.
Task shifting: rational redistribution of tasks among health workforce teams: global recommendations and guidelines. Geneva: World Health Organization, The United States President's Emergency Plan for AIDS Relief, Joint United Nations Programme on HIV/AIDS; 2008. [3 March 2015]. http://www​.who.int/healthsystems​/TTR-TaskShifting.pdf.
18.
Baggaley R, Curran K, Johnson C, Sands A, Brostrom M, Andreeva V. Test for triage: a new approach to community-based testing and counselling; Paper presented at: HIV Research for Prevention; 2014 October 30; Cape Town, South Africa.
19.
Constantine N, Saville R, Dax E. Retroviral testing and quality assurance: essentials for laboratory diagnosis Halifax. Canada: MedMira Laboratories educational grant; 2005.
20.
90-90-90. Ambitious treatment targets: writing the final chapter of the AIDS epidemic – a discussion paper. Geneva: Joint United Nations Programme on HIV/AIDS; 2014. [3 March 2015]. http://www​.unaids.org​/en/resources/documents/2014/90-90-90.
21.
Hensen B, Baggaley R, Wong VJ, Grabbe KL, Shaffer N, Lo YR, et al. Universal voluntary HIV testing in antenatal care settings: a review of the contribution of provider-initiated testing & counselling. Trop Med Int Health. 2012;17(1):59–70. [PubMed: 22032300]
22.
Kennedy CE, Fonner VA, Sweat MD, Okero FA, Baggaley R, O'Reilly KR. Provider-initiated HIV testing and counseling in low- and middle-income countries: a systematic review. AIDS Behav. 2013;17(5):1571–90. [PMC free article: PMC3927322] [PubMed: 22752501]
23.
Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505. [PMC free article: PMC3200068] [PubMed: 21767103]
24.
Progress report on the global health sector response. Geneva: World Health Organization; 2014. [22 May 2015]. http://www​.who.int/hiv​/pub/progressreports/update2014/en/
25.
Staveteig S, Wang S, Head SK, Bradley SEK, Nybro E. Demographic patterns of HIV testing uptake in sub-Saharan Africa. Calverton (MD): ICF International; 2013.
26.
How AIDS changed everything — MDG6: 15 years, 15 lessons of hope from the AIDS response. Geneva: Joint United Nations Programme on HIV/AIDS; 2015. [July 2015]. http://www​.unaids.org​/sites/default/files​/media_asset/MDG6Report_en.pdf.
27.
Kankasa C, Carter RJ, Briggs N, Bulterys M, Chama E, Cooper ER, et al. Routine offering of HIV testing to hospitalized pediatric patients at university teaching hospital, Lusaka, Zambia: acceptability and feasibility. J Acquir Immune Defic Syndr. 2009;51(2):202–8. [PMC free article: PMC5117627] [PubMed: 19504732]
28.
Wanyenze RK, Nawavvu C, Ouma J, Namale A, Colebunders R, Kamya MR. Provider-initiated HIV testing for paediatric inpatients and their caretakers is feasible and acceptable. Trop Med Int Health. 2010;15(1):113–9. [PubMed: 19891756]
29.
Rollins N, Mzolo S, Moodley T, Esterhuizen T, van Rooyen H. Universal HIV testing of infants at immunization clinics: an acceptable and feasible approach for early infant diagnosis in high HIV prevalence settings. AIDS. 2009;23(14):1851–7. [PubMed: 19491653]
30.
Boender TS, Sigaloff KC, Kayiwa J, Musiime V, Calis JC, Hamers RL, et al. Barriers to initiation of pediatric HIV treatment in Uganda: a mixed-method study. AIDS Res Treat. 2012;2012:817506. [PMC free article: PMC3286886] [PubMed: 22400106]
31.
Motswere-Chirwa C, Voetsch A, Letsholathebe V, Lekone P, Machakaire E, Legwaila K, et al. Follow-up of infants diagnosed with HIV – early infant diagnosis program, Francistown, Botswana, 2005-2012. Atlanta: Center of Disease Control and Prevention; MMWR Morb Mortal Wkly Rep. 2014 Feb 21;63(7):158–60. [PMC free article: PMC4584761] [PubMed: 24553200]
32.
Global report: UNAIDS report on the global AIDS epidemic. Geneva: Joint United Nations Programme on HIV/AIDS; 2013. [3 March 2015]. http://www​.unaids.org​/sites/default/files​/en/media/unaids/contentassets​/documents​/epidemiology/2013/gr2013​/UNAIDS_Global_Report_2013_en.pdf.
33.
Philbin MM, Tanner AE, DuVal A, Ellen JM, Xu J, Kapogiannis B, et al. Factors affecting linkage to care and engagement in care for newly diagnosed HIV-positive adolescents within fifteen adolescent medicine clinics in the United States. AIDS Behav. 2014;18(8):1501–10. [PMC free article: PMC4000283] [PubMed: 24682848]
34.
Global update on HIV treatment 2013: results, impact and opportunities. Geneva: World Health Organization, United Nations Children's Fund, Joint United Nations Programme on HIV/AIDS; 2013. [5 March 2015]. http://apps​.who.int/iris​/bitstream/10665​/128048/1/9789241507431_eng.pdf?ua=1.
35.
Kerr T, Hayashi K, Ti L, Kaplan K, Suwannawong P, Wood E. The impact of compulsory drug detention exposure on the avoidance of healthcare among injection drug users in Thailand. Int J Drug Policy. 2014;25(1):171–4. [PubMed: 23860470]
36.
Access to HIV prevention and treatment for men who have sex with men: findings from the 2012 Global Men's Health and Rights Study (GMHR). Oakland (CA): Global Forum on MSM & HIV; 2012. [3 March 2015]. http://www​.msmgf.org​/files/msmgf/documents/GMHR_2012.pdf.
37.
Kranzer K, Govindasamy D, Ford N, Johnston V, Lawn SD. Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review. J Int AIDS Soc. 2012;15(2):17383. [PMC free article: PMC3503237] [PubMed: 23199799]
38.
Rosen S, Fox MP. Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med. 2011;8(7):e1001056. [PMC free article: PMC3139665] [PubMed: 21811403]
39.
Siedner MJ, Ng CK, Bassett IV, Katz IT, Bangsberg DR, Tsai AC. Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002-2013: a meta-analysis. Clin Infect Dis. 2015;60(7):1120–7. [PMC free article: PMC4366582] [PubMed: 25516189]
40.
Johnson C, Sands A, Fonner V, Tsui S, Wong V, Obermeyer C, et al. Are we delivering the wrong results?: examining misclassification of HIV status and false positive test results; Paper presented at: African Society for Laboratory Medicine; 2014 Nov 30–Dec 5; Cape Town, South Africa.
41.
Flynn D, Johnson C, Sands A, Wong V, Baggaley R. A global analysis of the role of lay providers in national HIV testing and counseling policies; Paper presented at: 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention; 2015 July 19-22; Vancouver, Canada.
42.
Shanks L, Klarkowski D, O'Brien DP. False positive HIV diagnoses in resource limited settings: operational lessons learned for HIV programmes. PLoS One. 2013;8(3):e59906. [PMC free article: PMC3603939] [PubMed: 23527284]
43.
Integrated HIV program report January–March 2014. Lilongwe: Goverment of Malawi Ministry of Health; 2014.
44.
Service delivery approaches for HIV testing and counselling: a strategic framework. Geneva: World Health Organization; 2012. [3 March 2015]. http://www​.who.int/hiv​/pub/vct/htc_framework/en/
45.
Handbook for guideline development. Geneva: World Health Organization; 2014. [22 March 2015]. http://www​.who.int/kms/handbook_2nd_ed​.pdf.
46.
Operational guidelines on HIV testing and counselling of infants, children and adolescents for service providers in the African region. Brazzaville: WHO Regional Office for Africa; 2014. [3 March 2015]. http://www​.afro.who.int​/en/clusters-a-programmes​/dpc/acquired-immune-deficiency-syndrome​/features/2883-operational-guidelines-on-hiv-testing-and-counselling-of-infants-children-and-adolescents-for-service-providers-in-the-african-region​.html.
47.
Vidanapathirana J, Absrmson M, Formes A, Fairley C. Mass media interventions for promoting HIV testing. Cochrane Database Syst Rev. 2005;3 (CD004775) [PubMed: 16034948]
48.
Marum E, Morgan G, Hightower A, Ngare C, Taegtmeyer M. Using mass media campaigns to promote voluntary counseling and HIV-testing services in Kenya. AIDS. 2008;22(15):2019–24. [PubMed: 18784464]
49.
Guideline on HIV disclosure counselling for children up to 12 years of age. Geneva: World Health Organization; 2011. [22 May 2015]. http://www​.who.int/hiv​/pub/hiv_disclosure/en/ [PubMed: 26158185]
50.
Community service organizations in action: scaling up HIV testing and counselling among key populations in Asia and the Pacific. Phnom Penh: Khmer HIV/AIDS NGO Alliance (KHANA); 2014.
51.
Marum E, Baggaley R. Less and more: condensed HIV counselling and enhanced connection to care. Lancet Glob Health. 2013;1(3):e117–8. [PubMed: 25104249]
52.
Wanyenze RK, Kamywa MR, Fatch R, Mayanja-Kizza H, Baveewo S, Szekeres G, et al. Abbreviated HIV counselling and testing and enhanced referral to care in Uganda: a factorial randomised controlled trial. Lancet Glob Health. 2013;1(3):e137–45. [PMC free article: PMC4129546] [PubMed: 25104262]
53.
Revised national TB control programme, India – annual status report. New Dehli: TB India; 2014. [25 March 2015]. http://www​.tbcindia.nic​.in/pdfs/TB%20INDIA%202014.pdf.
54.
HIV and adolescents: guidance for HIV testing and counseling and care for adolescents living with HIV. Geneva: World Health Organization; 2013. [5 March 2015]. http://www​.who.int/hiv​/pub/guidelines/adolescents/en/ [PubMed: 25032477]
55.
Adolescent HIV testing, counselling and care: implementation for health providers and planners. Geneva: World Health Organization; 2013. [20 April 2015]. http://apps​.who.int/adolescent​/hiv-testing-treatment​/page/Informed​_consent_and_HIV_testing.
56.
Metsch LR, Feaster DJ, Gooden L, Schackman BR, Matheson T, Das M, et al. Effect of risk-reduction counseling with rapid HIV testing on risk of acquiring sexually transmitted infections: the AWARE randomized clinical trial. JAMA. 2013;310(16):1701–10. [PMC free article: PMC4110051] [PubMed: 24150466]
57.
WHO reminds national programmes to retest all newly diagnosed people with HIV. WHO information note – 22 October 2014. Geneva: World Health Organization; 2014. [18 March 2015]. http://www​.who.int/hiv​/pub/vct/retest-newly-diagnosed-plhiv-full/en/
58.
Brief sexuality-related communication: recommendations for a public health approach. Geneva: World Health Organization; 2015. [2 April 2015]. http://www​.who.int/reproductivehealth​/publications​/sexual_health​/sexuality-related-communication/en/ [PubMed: 26290928]
59.
Shamu S, Zarowsky C, Shefer T, Temmerman M, Abrahams N. Intimate partner violence after disclosure of HIV test results among pregnant women in Harare, Zimbabwe. PLoS One. 2014;9(10):e109447. [PMC free article: PMC4211664] [PubMed: 25350001]
60.
Wagman JA, Gray RH, Campbell JC, Thoma M, Ndyanabo A, Ssekasanvu J, et al. Effectiveness of an integrated intimate partner violence and HIV prevention intervention in Rakai, Uganda: analysis of an intervention in an existing cluster randomised cohort. Lancet Global Health. 2015;3(1):23–33. [PMC free article: PMC4370228] [PubMed: 25539966]
61.
Hagan H, Pouget ER, Des Jarlais DC. A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs. J Infect Dis. 2011;204(1):74–83. [PMC free article: PMC3105033] [PubMed: 21628661]
62.
Milloy MJ, Montaner J, Wood E. Barriers to HIV treatment among people who use injection drugs: implications for ‘treatment as prevention’ Curr Opin HIV AIDS. 2012;7(4):332–8. [PubMed: 22576468]
63.
Essential prevention and care interventions for adults and adolescents living with HIV in resource-limited settings. Geneva: World Health Organization; 2008. [3 March 2015]. http://www​.who.int/hiv​/topics/prevention_and_care/en/
64.
Retention in HIV programmes: defining the challenges and identifying solutions: meeting report. Geneva: World Health Organization; 2012.
65.
Govindasamy D, Ford N, Kranzer K. Risk factors, barriers and facilitators for linkage to antiretroviral therapy care: a systematic review. AIDS. 2012;26(16):2059–67. [PubMed: 22781227]
66.
Johnson C, Wong V, Baggaley R, Thaddeus S, Brown C. Three delays and linkage to care: a systematic review of barriers affecting initial enrolment in care among HIV diagnosed persons; Paper presented at: International Conference on AIDS and STIs in Africa; 2013 December 7-11; Cape Town, South Africa.
67.
Hallett TB, Eaton JW. A side door into care cascade for HIV-infected patients? J Acquir Immune Defic Syndr. 2013;63 Suppl 2:S228–32. [PubMed: 23764640]
68.
Barnabas R, van Rooyen H, Tumwesigye E, Murane P, Baeten J, Humphries H, et al. Initiation of antiretroviral therapy and viral suppression after home HIV testing and counselling in KwaZulu-Natal, South Africa, and Mbarara district, Uganda: a prospective,observational intervention study. Lancet HIV. 2014;1:e68–76. [PMC free article: PMC4292844] [PubMed: 25601912]
69.
MacPherson P, Lalloo DG, Webb EL, Maheswaran H, Choko AT, Makombe SD, et al. Effect of optional home initiation of HIV care following HIV self-testing on antiretroviral therapy initiation among adults in Malawi: a randomized clinical trial. JAMA. 2014;312(4):372–9. [PMC free article: PMC4118051] [PubMed: 25038356]
70.
van Rooyen H, Barnabas R, Baeten JM, Phakathi Z, Joseph P, Krows M, Hong T, et al. High HIV testing uptake and linkage to care in a novel program of home-based HIV counseling and testing with facilitated referral in KwaZulu-Natal, South Africa. J Acquir Immune Defic Syndr. 2013;64(1):e1–e8. [PMC free article: PMC3744613] [PubMed: 23714740]
71.
Larson BA, Schnippel K, Ndibongo B, Xulu T, Brennan A, Long L, et al. Rapid point-of-care CD4 testing at mobile HIV testing sites to increase linkage to care: an evaluation of a pilot program in South Africa. J Acquir Immune Defic Syndr. 2012;61(2):e13–7. [PMC free article: PMC3458178] [PubMed: 22659650]
72.
Hyle EP, Jani I, Lehe J, Su AE, Wood R, Quevedo J, et al. The clinical and economic impact of point-of-care CD4 testing in Mozambique and other resource-limited settings: a cost-effectiveness analysis. PLoS Med. 2014;11(9):e1001725. [PMC free article: PMC4165752] [PubMed: 25225800]
73.
Jani IV, Sitoe NE, Alfai ER, Chongo PL, Quevedo JI, Rocha BM, et al. Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: an observational cohort study. Lancet. 2011;378(9802):1572–9. [PubMed: 21951656]
74.
Wynberg E CG, Shroufi A, Reid SD, Ford N. Impact of point-of-care CD4 testing on linkage to HIV care: a systematic review. J Int AIDS Soc. 2014;(17):18809. [PMC free article: PMC3898050] [PubMed: 24447595]
75.
Nsigaye R, Wringe A, Roura M, Kalluvya S, Urassa M, Busza J, et al. From HIV diagnosis to treatment: evaluation of a referral system to promote and monitor access to antiretroviral therapy in rural Tanzania. J Int AIDS Soc. 2009;12:31. [PMC free article: PMC2788344] [PubMed: 19906291]
76.
Decroo T, Rasschaert F, Telfer B, Remartinez D, Laga M, Ford N. Community-based antiretroviral therapy programs can overcome barriers to retention of patients and decongest health services in sub-Saharan Africa: a systematic review. Int Health. 2013;5(3):169–79. [PubMed: 24030268]
77.
Hatcher AM, Turan JM, Leslie HH, Kanya LW, Kwena Z, Johnson MO, et al. Predictors of linkage to care following community-based HIV counseling and testing in rural Kenya. AIDS Behav. 2012;16(5):1295–307. [PMC free article: PMC3590795] [PubMed: 22020756]
78.
McCollum ED, Preidis GA, Kabue MM, Singogo EB, Mwansambo C, Kazembe PN, et al. Task shifting routine inpatient pediatric HIV testing improves program outcomes in urban Malawi: a retrospective observational study. PLoS One. 2010;5(3):e9626. [PMC free article: PMC2835755] [PubMed: 20224782]
79.
Wouters E, Van Damme W, van Rensburg D, Masquillier C, Meulemans H. Impact of community-based support services on antiretroviral treatment programme delivery and outcomes in resources-limited countries: a systematic review. BMC Health Serv Res. 2012;12:194. [PMC free article: PMC3476429] [PubMed: 22776682]
80.
Pop-Eleches C, Thirumurthy H, Habyarimana JP, Zivin JG, Goldstein MP, de Walque D, et al. Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS. 2011;25(6):825–34. [PMC free article: PMC3718389] [PubMed: 21252632]
81.
Ivers LC, Chang Y, Gregory Jerome J, Freedberg KA. Food assistance is associated with improved body mass index, food security and attendance at clinic in an HIV program in central Haiti: a prospective observational cohort study. AIDS Res Ther. 2010;7:33. [PMC free article: PMC2940780] [PubMed: 20796284]
82.
Lester RT, Ritvo P, Mills EJ, Kariri A, Karanja S, Chung MH, et al. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet. 2010;376(9755):1838–45. [PubMed: 21071074]
83.
Craw J, Gardner L, Rossman A, Gruber D, Noreen O, Jordan D, et al. Structural factors and best practices in implementing a linkage to HIV care program using the ARTAS model. BMC Health Serv Res. 2010;10:246. [PMC free article: PMC2933679] [PubMed: 20727189]
84.
Willis S, Castel AD, Ahmed T, Olejemeh C, Frison L, Kharfen M. Linkage, engagement, and viral suppression rates among HIV-infected persons receiving care at medical case management programs in Washington, DC. J Acquir Immune Defic Syndr. 2013;64(1) [PMC free article: PMC3844615] [PubMed: 23982662]
85.
Bocour A, Renaud T, Udeagu C, Shepard C. HIV partner services are associated with earlier diagnosis and linkage to HIV medical care; Paper presented at: 19th International AIDS Conference; 2012 July 22-27; Washington DC, USA.
86.
Mtambalike T. Elizabeth Glaser Pediatric AIDS Foundation (EGPAF): improving the continuum of care by promoting male involvement in PMTCT in Nzega District, Tanzania; Paper presented at: 19th International AIDS Conference; 2012 July 22-27; Washington DC, USA.
87.
Brown LB, Miller WC, Kamanga G, Nyirenda N, Mmodzi P, Pettifor A, et al. HIV partner notification is effective and feasible in sub-Saharan Africa: opportunities for HIV treatment and prevention. J Acquir Immune Defic Syndr. 2011;56(5):437–42. [PMC free article: PMC3207356] [PubMed: 22046601]
88.
Henley C, Forgwei G, Welty T, Golden M, Adimora A, Shields R, et al. Scale-up and case-finding effectiveness of an HIV partner services program in Cameroon: an innovative HIV prevention intervention for developing countries. Sex Transm Dis. 2013;40(12):909–14. [PMC free article: PMC4521599] [PubMed: 24220349]
89.
Finitsis DJ, Pellowski JA, Johnson BT. Text message intervention designs to promote adherence to antiretroviral therapy (ART): a meta-analysis of randomized controlled trials. PLoS One. 2014;9(2):e88166. [PMC free article: PMC3914915] [PubMed: 24505411]
90.
Medley A, Bachanas P, Grillo M, Hasen N, Amanyeiwe U. Integrating prevention interventions for people living with HIV into care and treatment programs: a systematic review of the evidence. J Acquir Immune Defic Syndr. 2015;68 Suppl 3:S286–96. [PMC free article: PMC4666299] [PubMed: 25768868]
91.
HIV test-treat-retain cascade analysis: guide and tools. Cairo: WHO Regional Office for the Eastern Mediterranean; 2014. [21 March 2015]. http://applications​.emro​.who.int/dsaf/EMROPUB_2014_EN_1639​.pdf?ua=1.
92.
Positive health, dignity and prevention: operational guidelines. Amsterdam, Geneva: The Global Network of People Living with HIV, Joint United Nations Programme on HIV/AIDS; 2013. [12 March 2015]. http://www​.unaids.org​/sites/default/files​/media_asset/20130802​_Positive_Health_Dignity​_Prevention_Operational​_Guidelines_0.pdf.
93.
Coma J, Macarringue L, Mahomed M, Bossemeyer D, Necochea E, Cummings B, et al. Referrals by community-based lay counselors in Mozambique increase utilization of voluntary medical male circumcision (VMMC) services; Paper presented at: 7th International AIDS Society Conference on HIV pathogenesis, treatment and prevention;; 2013 June 30–July 3; Kuala Lumpur, Malaysia.
94.
Strategic framework for referral and linkages between HCT and chronic HIV care services in Ethiopia. Addis Ababa: Federal HIV/AIDS Prevention and Control Office; 2009. [3 April 2015]. http://www​.etharc.org/index​.php/resources​/download/finish/33/420.
95.
Consolidated strategic information guide for HIV in the health sector. Geneva: World Health Organization; 2015. [22 May 2015]. http://www​.who.int/hiv​/pub/guidelines/strategic-information-guidelines/en/ [PubMed: 26110192]
96.
Metrics for monitoring the cascade of HIV testing, care and treatment services in Asia and the Pacific. Geneva: World Health Organization; 2014. [21 March 2015]. http://www​.wpro.who.int/hiv/hiv_metrics​.pdf.
97.
The quality of HIV-related point-of-care testing: ensuring reliability and accuracy of test results. Geneva: World Health Organization; (in press)
98.
International Planned Parenthood Federation; United Nations Population Fund; World Health Organization; Joint United Nations Programme on HIV/AIDS; Global Network of People Living with HIV; International Community of Women with HIV/AIDS; Young Positives. Rapid assessment tool for sexual & reproductive health and HIV linkages: a generic guide. London: International Planned Parenthood Federation; 2009. [22 May 2015]. http://www​.unfpa.org​/resources/rapid-assessment-tool-sexual-reproductive-health-and-hiv-linkages.
99.
World Health Organization; United Nations Population Fund; Joint United Nations Programme on HIV/AIDS; Global Network of Sex Work Projects; The World Bank. Implementing comprehensive HIV/STI programmes with sex workers: practical approaches from collaborative interventions. Geneva: World Health Organization; 2013. [9 March 2015]. http://apps​.who.int/iris​/bitstream/10665​/90000/1/9789241506182_eng.pdf?ua=1.
100.
Walensky R, Reichmann W, Arbelaez C, Wright E, Katz J, Seage G, et al. Counselor- versus provider-based HIV screening in the emergency department: results from the universal screening for HIV Infection in the Emergency Room (USHER) randomized controlled trial. Ann Emerg Med. 2011;58(Suppl 1):S126–S32. [PMC free article: PMC3268065] [PubMed: 21684391]
101.
Champenois K, Le Gall JM, Jacquemin C, Jean S, Martin C, Rios L, et al. ANRS-COM'TEST: description of a community-based HIV testing intervention in non-medical settings for men who have sex with men. BMJ Open. 2012;2(2):e000693. [PMC free article: PMC3323802] [PubMed: 22466158]
102.
Lorente N, Preau M, Vernay-Vaisse C, Mora M, Blanche J, Otis J, et al. Expanding access to non-medicalized community-based rapid testing to men who have sex with men: an urgent HIV prevention intervention (the ANRS-DRAG study). PLoS One. 2013;8(4):e61225. [PMC free article: PMC3628708] [PubMed: 23613817]
103.
Molesworth AM, Ndhlovu R, Banda E, Saul J, Ngwira B, Glynn JR, et al. High accuracy of home-based community rapid HIV testing in rural Malawi. J Acquir Immune Defic Syndr. 2010;55(5):625–30. [PMC free article: PMC3248920] [PubMed: 21934554]
104.
Bemelmans M, van den Akker T, Ford N, Philips M, Zachariah R, Harries A, et al. Providing universal access to antiretroviral therapy in Thyolo, Malawi through task shifting and decentralization of HIV/AIDS care. Trop Med Int Health. 2010;15(12):1413–20. [PubMed: 20958897]
105.
Jackson D, Naik R, Tabana H, Pillay M, Madurai S, Zembe W, et al. Quality of home-based rapid HIV testing by community lay counsellors in a rural district of South Africa. J Int AIDS Soc. 2013;16:18744. [PMC free article: PMC3830054] [PubMed: 24241957]
106.
Fylkesnes K, Sandoy IF, Jurgensen M, Chipimo PJ, Mwangala S, Michelo C. Strong effects of home-based voluntary HIV counselling and testing on acceptance and equity: a cluster randomised trial in Zambia. Soc Sci Med. 2013;86:9–16. [PubMed: 23608089]
107.
Iwu EN, Holzemer WL. Task shifting of HIV management from doctors to nurses in Africa: clinical outcomes and evidence on nurse self-efficacy and job satisfaction. AIDS Care. 2014;26(1):42–52. [PubMed: 23701374]
108.
Jurgensen M, Sandoy IF, Michelo C, Fylkesnes K. Effects of home-based voluntary counselling and testing on HIV-related stigma: findings from a cluster-randomized trial in Zambia. Soc Sci Med. 2013;81:18–25. [PubMed: 23422056]
109.
Leon N, Naidoo P, Mathews C, Lewin S, Lombard C. The impact of provider-initiated (opt-out) HIV testing and counseling of patients with sexually transmitted infection in Cape Town, South Africa: a controlled trial. Implement Sci. 2010;5:8. [PMC free article: PMC2825497] [PubMed: 20205841]
110.
Kanal K, Chou TL, Sovann L, Morikawa Y, Mukoyama Y, Kakimoto K. Evaluation of the proficiency of trained non-laboratory health staffs and laboratory technicians using a rapid and simple HIV antibody test. AIDS Res Ther. 2005;2(1):5. [PMC free article: PMC1156864] [PubMed: 15907202]
111.
What do we know about them? The state of evidence on programmes, activities, costs and impact on health outcomes of using community health workers. Geneva: World Health Organization; 2007. [22 May 2015]. http://www​.hrhresourcecenter​.org/node/1587.
112.
Lewin SA, Dick J, Pond P, Zwarenstein M, Aja G, van Wyk B, et al. Lay health workers in primary and community health care. Cochrane Database Syst Rev. 2005;(1) CD004015. [PubMed: 15674924]
113.
Laurant M, Reeves D, Hermens R, Braspenning J, Grol R, Sibbald B. Substitution of doctors by nurses in primary care. Cochrane Database Syst Rev. 2005;(2) CD001271. [PubMed: 15846614]
114.
Callaghan M, Ford N, Schneider H. A systematic review of task-shifting for HIV treatment and care in Africa. Hum Resour Health. 2010;8:8. [PMC free article: PMC2873343] [PubMed: 20356363]
115.
Donnell-Fink L, Reichmann WM, Arbelaez C, Case AL, Katz JN, Losina E, et al. Patient satisfaction with rapid HIV testing in the emergency department. Ann Emerg Med. 2011;58(1 Suppl 1):S49–52. [PMC free article: PMC3260474] [PubMed: 21684408]
116.
Hecht CR, Smith MD, Radonich K, Kozlovskaya O, Totten VY. A comparison of patient and staff attitudes about emergency department-based HIV testing in 2 urban hospitals. Ann Emerg Med. 2011;58(1 Suppl 1):S28–32. e1–4. [PubMed: 21684404]
117.
Chirawu P, Langhaug L, Mavhu W, Pascoe S, Dirawo J, Cowan F. Acceptability and challenges of implementing voluntary counselling and testing (VCT) in rural Zimbabwe: evidence from the Regai Dzive Shiri Project. AIDS Care. 2010;22(1):81–8. [PubMed: 20390484]
118.
deGraft-Johnson J, Paz-Soldan V, Kasote A, Tsui A. HIV voluntary counseling and testing service preferences in a rural Malawi population. AIDS Behav. 2005;9(4):475–84. [PubMed: 16261266]
119.
Ledikwe JH, Kejelepula M, Maupo K, Sebetso S, Thekiso M, Smith M, et al. Evaluation of a well-established task-shifting initiative: the lay counselor cadre in Botswana. PLoS One. 2013;8(4):e61601. [PMC free article: PMC3621674] [PubMed: 23585912]
120.
Tucker J, Muessig K, Cui R, Bien C, Lo E, Lee R, et al. Organizational characteristics of HIV/syphilis testing services for men who have sex with men in South China: a social entrepreneurship analysis and implications for creating sustainable service models. BMC Infect Dis. 2015;14(601) [PMC free article: PMC4247875] [PubMed: 25422065]
121.
Bien CH, Muessig KE, Lee R, Lo EJ, Yang LG, Yang B, et al. HIV and syphilis testing preferences among men who have sex with men in South China: a qualitative analysis to inform sexual health services. PLoS One. 2015;10(4):e0124161. [PMC free article: PMC4395264] [PubMed: 25875336]
122.
Regional report: MSM and HIV counselling and testing in Asia and the Pacific. Bangkok: Asia Pacific Coalition on Men's Sexual Health; 2014. [2 March 2015]. http://www​.apcom.org/printpdf/28983.
123.
Grabbe KL, Menzies N, Taegtmeyer M, Emukule G, Angala P, Mwega I, et al. Increasing access to HIV counseling and testing through mobile services in Kenya: strategies, utilization, and cost-effectiveness. J Acquir Immune Defic Syndr. 2010;54(3):317–23. [PMC free article: PMC3225204] [PubMed: 20453819]
124.
McConnel CE, Stanley N, du Plessis JA, Pitter CS, Abdulla F, Coovadia HM, et al. The cost of a rapid-test VCT clinic in South Africa. S Afr Med J. 2005;95(12):968–71. [PubMed: 16465359]
125.
Menzies NA, Homsy J, Chang Pitter JY, Pitter C, Mermin J, Downing R, et al. Cost-effectiveness of routine rapid human immunodeficiency virus antibody testing before DNA-PCR testing for early diagnosis of infants in resource-limited settings. Pediatr Infect Dis J. 2009;28(9):819–25. [PubMed: 20050391]
126.
Guidance on provider-initiated HIV testing and counselling in health facilities. Geneva: World Health Organization; 2007. [22 March 2015]. http://www​.who.int/hiv​/pub/vct/pitc2007/en/
127.
Mocroft A, Lundgren JD, Sabin ML, Monforte A, Brockmeyer N, Casabona J, et al. Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE). PLoS Med. 2013;10(9):e1001510. [PMC free article: PMC3796947] [PubMed: 24137103]
128.
d'Almeida K, Kierzek G, de Truchis P, Le Vu S, Pateron D, Renaud B, et al. Modest public health impact of nontargeted human immunodeficency screening in 29 emergency departments. Arch Intern Med. 2011;172(1):12–20. [PubMed: 22025095]
129.
HIV indicator conditions: guidance for implementing HIV testing in adults in health care settings. Copenhagen: HIV in Europe; 2012. [22 March 2015]. http://hiveurope​.eu/Portals/0/Guidance​.pdf.pdf.
130.
Systematic screening for active tuberculosis: principles and recommendations. Geneva: World Health Organization; 2013. [7 March 2015]. http://www​.who.int/tb/tbscreening/en/ [PubMed: 25996015]
131.
Corneli A, Jarrett NM, Sabue M, Duvall S, Bahati E, Behets F, et al. Patient and provider perspectives on implementation models of HIV counseling and testing for patients with TB. Int J Tuberc Lung Dis. 2008;12(3 Suppl 1):79–84. [PubMed: 18302828]
132.
Global tuberculosis report. Geneva: World Health Organization; 2014. [20 March 2015]. http://apps​.who.int/iris​/bitstream/10665​/137094/1/9789241564809_eng.pdf?ua=1.
133.
Dalal S, Lee CW, Farirai T, Schilsky A, Goldman T, Moore J, et al. Provider-initiated HIV testing and counseling: increased uptake in two public community health centers in South Africa and implications for scale-up. PLoS One. 2011;6(11):e27293. [PMC free article: PMC3219659] [PubMed: 22114668]
134.
Socias ME, Hermida L, Singman M, Kulgis G, Diaz Armas A, Cando O, et al. Routine HIV testing among hospitalized patients in Argentina. Is it time for a policy change? PLoS One. 2013;8(7):e69517. [PMC free article: PMC3729969] [PubMed: 23936034]
135.
Walensky R, Losina E, Steger-Craven K, Freedberg K. Identifying undiagnosed human immunodeficiency virus: the yield of routine, voluntary inpatient testing. Arch Intern Med. 2002;2002(162):8. [PubMed: 11966339]
136.
Devi P, Arora U, Yadav S, Malhotra S. Seroprevalence of HIV infection among the patients attending various emergency departments in a tertiary care hospital. Indian J Sex Transm Dis. 2010;31(1):27–9. [PMC free article: PMC3140145] [PubMed: 21808433]
137.
Sengayi M, Babb C, Egger M, Urban MI. HIV testing and burden of HIV infection in black cancer patients in Johannesburg, South Africa: a cross-sectional study. BMC Cancer. 2015;15(1):144. [PMC free article: PMC4434805] [PubMed: 25884599]
138.
Mutanga JN, Raymond J, Towle MS, Mutembo S, Fubisha RC, Lule F, et al. Institutionalizing provider-initiated HIV testing and counselling for children: an observational case study from Zambia. PLoS One. 2012;7(4):e29656. [PMC free article: PMC3335043] [PubMed: 22536311]
139.
Kranzer K, Meghji J, Bandason T, Dauya E, Mungofa S, Busza J, et al. Barriers to provider-initiated testing and counselling for children in a high HIV prevalence setting: a mixed methods study. PLoS Med. 2014;11(5):e1001649. [PMC free article: PMC4035250] [PubMed: 24866209]
140.
Progress in voluntary medical male circumcision service provision – Kenya, 2008-2011. MMWR Morb Mortal Wkly Rep. 2012;61(47):957–61. [PubMed: 23190568]
141.
Integration of provider initiated testing and counselling for HIV with voluntary medical male circumcision services. Washington (DC): Project SEARCH; 2013. [22 March 2015]. http://www​.jhsph.edu​/research/centers-and-institutes​/research-to-prevention​/publications​/Integration-hiv-vmmc.pdf.
142.
Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. Geneva: World Health Organization; 2011. [4 March 2015]. http://www​.who.int/tb​/challenges/hiv/ICF_IPTguidelines/en/
143.
Shetty PV, Granich RM, Patil AB, Sawant SK, Sahu S, Wares DF, et al. Cross-referral between voluntary HIV counselling and testing centres and TB services, Maharashtra, India, 2003-2004. Int J Tuberc Lung Dis. 2008;12(3 Suppl 1):26–31. [PubMed: 18302819]
144.
Ramachandran R, Chandrasekaran V, Muniyandi M, Jaggarajamma K, Bagchi A, Sahu S. Cross-referral between HIV counselling and testing centres and smear microscopy centres in Tamil Nadu. Int J Tuberc Lung Dis. 2009;13(2):221–5. [PubMed: 19146751]
145.
Kalichman SC, Pellowski J, Turner C. Prevalence of sexually transmitted co-infections in people living with HIV/AIDS: systematic review with implications for using HIV treatments for prevention. Sex Transm Infect. 2011;87(3):183–90. [PMC free article: PMC4317792] [PubMed: 21330572]
146.
Guidelines for the management of sexually transmitted infections. Geneva: World Health Organization; 2004. [2 March 2015]. http://www​.who.int/hiv/pub/sti/pub6/en/
147.
Dukers-Muijrers NH, Niekamp AM, Vergoossen MM, Hoebe CJ. Effectiveness of an opting-out strategy for HIV testing: evaluation of 4 years of standard HIV testing in a STI clinic. Sex Transm Infect. 2009;85(3):226–30. [PubMed: 19103641]
148.
Elimination of mother-to-child transmission (EMTCT) of HIV and syphilis: global guidance on criteria and processes for validation. Geneva: World Health Organization; 2014. [23 March 2015]. http://apps​.who.int/iris​/bitstream/10665​/112858/1/9789241505888_eng​.pdf?ua=1&ua=1.
149.
Mwapasa V, Rogerson SJ, Kwiek JJ, Wilson PE, Milner D, Molyneux ME, et al. Maternal syphilis infection is associated with increased risk of mother-to-child transmission of HIV in Malawi. AIDS. 2006;20(14):1869–77. [PubMed: 16954728]
150.
Investment case for EMTCT of syphilis. Geneva: World Health Organization; 2013. [22 April 2015]. http://apps​.who.int/iris​/bitstream/10665​/75480/1/9789241504348_eng.pdf.
151.
Treat train retain Task shifting: global recommendations and guidelines. Geneva: World Health Organization; 2007. [3 March 2015]. http://www​.who.int/healthsystems​/task_shifting/en/
152.
Labhardt ND, Motlomelo M, Cerutti B, Pfeiffer K, Kamele M, Hobbins MA, et al. Home-based versus mobile clinic HIV testing and counseling in rural Lesotho: a cluster-randomized trial. PLoS Med. 2014;11(12):e1001768. [PMC free article: PMC4267810] [PubMed: 25513807]
153.
Van Handel M, Mulatu M. Effectiveness of the U.S. national HIV testing day campaigns in promoting HIV testing: evidence from CDC-funded HIV testing sites, 2010. Public Health Rep. 2014;129(5):446–54. [PMC free article: PMC4116372] [PubMed: 25177056]
154.
Chamie G, Kwarisiima D, Clark TD, Kabami J, Jain V, Geng E, et al. Uptake of community-based HIV testing during a multi-disease health campaign in rural Uganda. PLoS One. 2014;9(1):e84317. [PMC free article: PMC3879307] [PubMed: 24392124]
155.
Lugada E, Millar D, Haskew J, Grabowsky M, Garg N, Vestergaard M, et al. Rapid implementation of an integrated large-scale HIV counseling and testing, malaria, and diarrhea prevention campaign in rural Kenya. PLoS One. 2010;5(8):e12435. [PMC free article: PMC2928737] [PubMed: 20865049]
156.
Corbett EL, Dauya E, Matambo R, Cheung YB, Makamure B, Bassett MT, et al. Uptake of workplace HIV counselling and testing: a cluster-randomised trial in Zimbabwe. PLoS Med. 2006;3(7):e238. [PMC free article: PMC1483908] [PubMed: 16796402]
157.
Collier AC, Van der Borght SF, Rinke de Wit T, Richards SC, Feeley FG. A successful workplace program for voluntary counseling and testing and treatment of HIV/AIDS at Heineken, Rwanda. Int J Occup Environ Health. 2007;13(1):99–106. [PubMed: 17427354]
158.
Charalambous S, Innes C, Muirhead D, Kumaranayake L, Fielding K, Pemba L, et al. Evaluation of a workplace HIV treatment programme in South Africa. AIDS. 2007;21 Suppl 3:S73–8. [PubMed: 17666964]
159.
Hermez J, Petrak J, Karkouri M, Riedner G. A review of HIV testing and counseling policies and practices in the Eastern Mediterranean region. AIDS. 2010;24 Suppl 2:S25–32. [PubMed: 20610945]
160.
Counselling and testing children for HIV in South Africa. Lancet. 2013;381(9865):424. [PubMed: 23399057]
161.
Patel D, Matyanga P, Nyamundaya T, Chimedza D, Webb K, Engelsmann B. Facilitating HIV testing, care and treatment for orphans and vulnerable children aged five years and younger through community-based early childhood development play centres in rural Zimbabwe. J Int AIDS Soc. 2012;15 Suppl 2:17404. [PMC free article: PMC3499882] [PubMed: 22789648]
162.
Ortega-Peluso C, Akkaya-Hocagil T, Leung SY, Rowe KA, Zielinski M, Tallon T, et al. Routine HIV testing capacity, practices, and perceptions among school-based health center providers in New York State after enactment of the 2010 amended HIV testing law. J Acquir Immune Defic Syndr. 2015;68 Suppl 1:S30–6. [PubMed: 25545491]
163.
Frohlich JA, Mkhize N, Dellar RC, Mahlase G, Montague CT, Abdool Karim Q. Meeting the sexual and reproductive health needs of high-school students in South Africa: experiences from rural KwaZulu-Natal. S Afr Med J. 2014;104(10):687–90. [PubMed: 25363055]
164.
Abdool Karim Q, Kharsany AB, Leask K, Ntombela F, Humphries H, Frohlich JA, et al. Prevalence of HIV, HSV-2 and pregnancy among high school students in rural KwaZulu-Natal, South Africa: a bio-behavioural cross-sectional survey. Sex Transm Infect. 2014;90(8):620–6. [PMC free article: PMC4759648] [PubMed: 24873967]
165.
Choko A. One year outcomes following community-based HIV self-testing: a prospective study in Malawi; Paper presented at: Conference on Retroviruses and Opportunistic Infections; 2014 March 3-6; Boston (MA), USA.
166.
Preparedness for HIV/AIDS service delivery: the 2005 Kenya health worker survey. Nairobi: National AIDS and STIs Control Programme; 2006. [22 April 2015]. http://pdf​.usaid.gov/pdf_docs/pnadk460​.pdf.
167.
Health worker access to HIV/TB prevention, treatment and care services in Africa: situational analysis and mapping of routine and current best practices. Geneva: World Health Organization, Global Health Workforce Alliance; 2007.
168.
Kebede B, Abate T, Mekonnen D. HIV self-testing practices among health care workers: feasibility and options for accelerating HIV testing services in Ethiopia. Pan Afr Med J. 2013;15:50. [PMC free article: PMC3786151] [PubMed: 24106578]
169.
Kalibala S, Tun W, Cherutich P, Nganga A, Oweya E, Oluoch P. Factors associated with acceptability of HIV self-testing among health care workers in Kenya. AIDS Behav. 2014;18 Suppl 4:S405–14. [PMC free article: PMC4933836] [PubMed: 24974123]
170.
Pant Pai N, Sharma J, Shivkumar S, Pillay S, Vadnais C, Joseph L, et al. Supervised and unsupervised self-testing for HIV in high- and low-risk populations: a systematic review. PLoS Med. 2013;10(4):e1001414. [PMC free article: PMC3614510] [PubMed: 23565066]
171.
Krause J, Subklew-Sehume F, Kenyon C, Colebunders R. Acceptability of HIV self-testing: a systematic literature review. BMC Public Health. 2013;13:735. [PMC free article: PMC3750621] [PubMed: 23924387]
172.
Figueroa C, Johnson C, Verster A, Baggaley R. Attitudes, values and preferences among key populations on HIV self-testing. AIDS Behav. 2015 [09 June 2015]; http://link​.springer​.com/article/10.1007/s10461-015-1097-8#. [PMC free article: PMC4598350] [PubMed: 26054390]
173.
Klausner J. Innovations in HIV self-testing delivery: vending machines, vouchers and US mail; Paper presented at: Pre-Conference on Retroviruses and Opportunistic Infections: Innovations in HIV Self-testing; 2015 February 23-26; Seattle, WA, USA.
174.
Choko AT, Desmond N, Webb EL, Chavula K, Napierala-Mavedzenge S, Gaydos CA, et al. The uptake and accuracy of oral kits for HIV self-testing in high HIV prevalence setting: a cross-sectional feasibility study in Blantyre, Malawi. PLoS Med. 2011;8(10):e1001102. [PMC free article: PMC3186813] [PubMed: 21990966]
175.
Okal J, Obare F, Matheka J, Tun W. Assessment of possible outlets for distribution of HIV oral self-test kits in Kenya; Paper presented at: 20th International AIDS Society Conference; 2014 July 20-25; Melbourne, Australia.
176.
Dong M, Regina R, Hlongwane S, Ghebremichael M, Wilson D, Dong K. Can laypersons in high-prevalence South Africa perform an HIV self-test accurately?; Paper presented at: 20th International AIDS Conference; 2014 July 20-25; Melbourne, Australia.
177.
Lee VJ, Tan SC, Earnest A, Seong PS, Tan HH, Leo YS. User acceptability and feasibility of self-testing with HIV rapid tests. J Acquir Immune Defic Syndr. 2007;45(4):449–53. [PubMed: 17554213]
178.
Peck RB, Lim JM, van Rooyen H, Mukoma W, Chepuka L, Bansil P, et al. What should the ideal HIV self-test look like? A usability study of test prototypes in unsupervised HIV self-testing in Kenya, Malawi, and South Africa. AIDS Behav. 2014;18 Suppl 4:S422–32. [PubMed: 24947852]
179.
Mavedezenge S, Cowan F. HIV self-testing among sex workers; Paper presented at: 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention;; 2015 July 19-24; Vancouver, Canada.
180.
Jaspard M, Le Moal G, Saberan-Roncato M, Plainchamp D, Langlois A, Camps P, et al. Finger-stick whole blood HIV-1/-2 home-use tests are more sensitive than oral fluid-based in-home HIV tests. PLoS One. 2014;9(6):e101148. [PMC free article: PMC4074152] [PubMed: 24971842]
181.
Cambiano V, Ford D, Mabugu T, Napierala Mavedzenge S, Miners A, Mugurungi O, et al. Assessment of the potential impact and cost-effectiveness of self-testing for HIV in low-income countries. J Infect Dis. 2015 [PMC free article: PMC4512606] [PubMed: 25767214]
182.
Brown AN, Djimeu EW, Cameron DB. A review of the evidence of harm from self-tests. AIDS Behav. 2014;18 Suppl 4:S445–9. [PMC free article: PMC4094790] [PubMed: 24989129]
183.
Kenya AIDS Indicator Survey: final report. Nairobi: National AIDS and STI Control Programme; 2014. [20 March 2015]. http://www​.nacc.or.ke​/attachments/article​/403/KAIS_II_2014_Final_Report.pdf.
184.
Summary of safety and effectiveness. Rockville (MD): United States Food and Drug Administration; 2012. [22 May 2015]. http://www​.fda.gov/downloads​/BiologicsBloodVaccines​/BloodBloodProducts​/ApprovedProducts​/PremarketApprovalsPMAs​/UCM312534.pdf.
185.
Seronet. Autotests VIH: la DGS s'explique. [Self-tests HIV: the DGS explains]. [31 May 2015]. [website] http://www​.seronet.info​/article/autotests-vih-la-dgs-sexplique-71823.
186.
BioSure HIV self test. Essex: BioSure (UK) Ltd; 2015. [31 May 2015]. [website] http://hivselftest​.co.uk/
187.
New progress and guidance on HIV diagnosis and treatment for infants and children. Geneva: World Health Organization; 2010. [22 May 2015]. http://www​.who.int/hiv​/pub/paediatric/Paediatricfactsheet​/en/
188.
Ahmed S, Kim M, Sugandhi N, Phelps B, Sabelli R, Young P, et al. Beyond early infant diagnosis: case finding strategies for identification of HIV-infected infants and children. AIDS. 2013;27(2):S235–45. [PMC free article: PMC4122794] [PubMed: 24361633]
189.
Matida LH, Santos NJ, Ramos AN Jr., Gianna MC, da Silva MH, Domingues CS, et al. Eliminating vertical transmission of HIV in Sao Paulo, Brazil: progress and challenges. J Acquir Immune Defic Syndr. 2011;57 Suppl 3:S164–70. [PubMed: 21857313]
190.
Resolution on involuntary sterilization and the protection of human rights in access to HIV services. Banjul: African Commission on Human and Peoples' Rights; 2013. [7 March 2015]. http://www​.achpr.org​/sessions/54th/resolutions/260/
191.
Gupta A, Bhosale R, Kinikar A, Gupte N, Bharadwaj R, Kagal A, et al. Maternal tuberculosis: a risk factor for mother-to-child transmission of human immunodeficiency virus. J Infect Dis. 2011;203(3):358–63. [PMC free article: PMC3071111] [PubMed: 21208928]
192.
Guidelines for assessing the utility of data from prevention of mother-to-child transmission. Geneva: World Health Organization, Joint United Nations Programme on HIV/AIDS Working Group on Global HIV/AIDS and STI Surveillance; 2013. [6 March 2015]. http://www​.who.int/hiv​/pub/surveillance/2013package​/module3/en/
193.
Maman D, Huerga H, Etard J-F, Chilima B, Ellman T, Mukui I, et al. Most breastfeeding women with high viral load are still undiagnosed in sub-Saharan Africa; Paper presented at: Conference on Retroviruses and Opportunistic Infections; 2015 February 21-23; Seattle (WA), USA.
194.
Statement on HIV testing and counseling: WHO, UNAIDS re-affirm opposition to mandatory HIV testing. Geneva: World Health Organization; 2012. [4 March 2015]. http://www​.who.int/hiv​/events/2012/world_aids_day​/hiv_testing_counselling/en/
195.
Desmond N, Corbett L. HIV self-testing for couples in resource-poor contexts in urban Malawi; Paper presented at: 20th International AIDS Conference; 2014 July 20-25; Melbourne, Australia.
196.
Kumwenda M, Munthali A, Phiri M, Mwale D, Gutteberg T, MacPherson E, et al. Factors shaping initial decision-making to self-test amongst cohabiting couples in urban Blantyre, Malawi. AIDS Behav. 2014;18 Suppl 4:S396–404. [PMC free article: PMC4102820] [PubMed: 24929834]
197.
Carballo-Dieguez A, Frasca T, Dolezal C, Balan I. Will gay and bisexually active men at high risk of infection use over-the-counter rapid HIV tests to screen sexual partners? J Sex Res. 2012;49(4):379–87. [PMC free article: PMC3600862] [PubMed: 22293029]
198.
Were WA, Mermin J, Wamai N, Awor AC, Bechange S, Moss S, et al. Undiagnosed HIV infection and couple HIV discordance among household members of HIV-infected people receiving antiretroviral therapy in Uganda. J Acquir Immune Defic Syndr. 2006;43(1):91–5. [PubMed: 16885775]
199.
Piot P, Bartos M, Larson H, Zewdie D, Mane P. Coming to terms with complexity: a call to action for HIV prevention. Lancet. 2008;372(9641):845–59. [PubMed: 18687458]
200.
Kaiser R, Bunnell R, Hightower A, Kim AA, Cherutich P, Mwangi M, et al. Factors associated with HIV infection in married or cohabitating couples in Kenya: results from a nationally representative study. PLoS One. 2011;6(3):e17842. [PMC free article: PMC3057989] [PubMed: 21423615]
201.
De Walque D. Sero-discordant couples in five African countries: implications for prevention strategies. Popul Dev Rev. 2007;33(3):501–23.
202.
Cornell M, McIntyre J, Myer L. Men and antiretroviral therapy in Africa: our blind spot. Trop Med Int Health. 2011;16(7):828–9. [PMC free article: PMC3749374] [PubMed: 21418449]
203.
Druyts E, Dybul M, Kanters S, Nachega J, Birungi J, Ford N, et al. Male sex and the risk of mortality among individuals enrolled in antiretroviral therapy programs in Africa: a systematic review and meta-analysis. AIDS. 2013;27(3):417–25. [PubMed: 22948271]
204.
Hensen B, Taoka S, Lewis JJ, Weiss HA, Hargreaves J. Systematic review of strategies to increase men's HIV-testing in sub-Saharan Africa. AIDS. 2014;28(14):2133–45. [PMC free article: PMC4819892] [PubMed: 25062091]
205.
Doherty T, Tabana H, Jackson D, Naik R, Zembe W, Lombard C, et al. Effect of home based HIV counselling and testing intervention in rural South Africa: cluster randomised trial. BMJ. 2013;346:f3481. [PMC free article: PMC3685510] [PubMed: 23766483]
206.
Sweat M, Morin S, Celentano D, Mulawa M, Singh B, Mbwambo J, et al. Community-based intervention to increase HIV testing and case detection in people aged 16-32 years in Tanzania, Zimbabwe, and Thailand (NIMH Project Accept, HPTN 043): a randomised study. Lancet Infect Dis. 2011;11(7):525–32. [PMC free article: PMC3156626] [PubMed: 21546309]
207.
Mohlala BK, Boily MC, Gregson S. The forgotten half of the equation: randomized controlled trial of a male invitation to attend couple voluntary counselling and testing. AIDS. 2011;25(12):1535–41. [PMC free article: PMC3514892] [PubMed: 21610487]
208.
Byamugisha R, Astrom AN, Ndeezi G, Karamagi CA, Tylleskar T, Tumwine JK. Male partner antenatal attendance and HIV testing in eastern Uganda: a randomized facility-based intervention trial. J Int AIDS Soc. 2011;14:43. [PMC free article: PMC3192699] [PubMed: 21914207]
209.
Ditekemena J, Matendo R, Koole O, Colebunders R, Kashamuka M, Tshefu A, et al. Male partner voluntary counselling and testing associated with the antenatal services in Kinshasa, Democratic Republic of Congo: a randomized controlled trial. Int J STD AIDS. 2011;22(3):165–70. [PubMed: 21464455]
210.
Sabapathy K, Van den Bergh R, Fidler S, Hayes R, Ford N. Uptake of home-based voluntary HIV testing in sub-Saharan Africa: a systematic review and meta-analysis. PLoS Med. 2012;9(12):e1001351. [PMC free article: PMC3514284] [PubMed: 23226107]
211.
Gordon MS, Kinlock TW, McKenzie M, Wilson ME, Rich JD. Rapid HIV testing for individuals on probation/parole: outcomes of an intervention trial. AIDS Behav. 2013;17(6):2022–30. [PMC free article: PMC3674156] [PubMed: 23536140]
212.
Beckwith CG, Nunn A, Baucom S, Getachew A, Akinwumi A, Herdman B, et al. Rapid HIV testing in large urban jails. Am J Public Health. 2012;102 Suppl 2:S184–6. [PMC free article: PMC3477921] [PubMed: 22401524]
213.
Mathews R, Johnson C, Verster A, Baggaley R. Review of community-based HIV testing and counselling among key populations. (unpublished data)
214.
Kane S, Dewan PK, Gupta D, Wi T, Das A, Singh A, et al. Large-scale public-private partnership for improving TB-HIV services for high-risk groups in India. Int J Tuberc Lung Dis. 2010;14(8):1066–8. [PubMed: 20626954]
215.
Evidence for action series: effectiveness of interventions to address HIV in prisons. Geneva: World Health Organization; 2007. [22 April 2015]. http://www​.who.int/hiv​/idu/OMS_E4Acomprehensive_WEB.pdf.
216.
Policy statement on HIV testing and counselling for refugees and other persons of concern to UNHCR. Geneva: United Nations High Commissioner for Refugees, World Health Organization, Joint United Nations Programme on HIV/AIDS; 2014. [23 March 2015]. http://www​.unhcr.org/53a816729.pdf.
217.
South African national HIV prevalence, incidence and behaviour survey, 2012. Cape Town: Human Sciences Research Council; 2014. [26 March 2015]. http://www​.hsrc.ac.za​/uploads/pageContent​/4565/SABSSM%20IV%20LEO%20final.pdf.
218.
219.
Baggaley R, Henson B, Ajose O, Grabbe K, Wong V, Schilsky A. From caution to urgency: the evolving response to HIV testing. Bull World Health Organ. 2012;90:652–8B. [PMC free article: PMC3442388] [PubMed: 22984309]
220.
Menzies N, Abang B, Wanyenze R, Nuwaha F, Mugisha B, Coutinho A, et al. The costs and effectiveness of four HIV counseling and testing strategies in Uganda. AIDS. 2009;23(3):395–401. [PubMed: 19114865]
221.
Topp SM, Li MS, Chipukuma JM, Chiko MM, Matongo E, Bolton-Moore C, et al. Does provider-initiated counselling and testing (PITC) strengthen early diagnosis and treatment initiation? Results from an analysis of an urban cohort of HIV-positive patients in Lusaka, Zambia. J Int AIDS Soc. 2014;15(2):17352. [PMC free article: PMC3494161] [PubMed: 23010377]
222.
Becker S, Taulo FO, Hindin MJ, Chipeta EK, Loll D, Tsui A. Pilot study of home-based delivery of HIV testing and counseling and contraceptive services to couples in Malawi. BMC Public Health. 2014;14:1309. [PMC free article: PMC4320475] [PubMed: 25526799]
223.
Parker LA, Jobanputra K, Rusike L, Mazibuko S, Okello V, Kerschberger B, et al. Feasibility and effectiveness of two community-based HIV testing models in rural Swaziland. Trop Med Int Health. 2015 [PMC free article: PMC4672714] [PubMed: 25753897]
224.
Smith JA, Sharma M, Levin C, Baeten JM, van Rooyen H, Celum C, et al. Cost-effectiveness of community-based strategies to strengthen the continuum of HIV care in rural South Africa: a health economic modelling analysis. Lancet HIV. 2015;2(4):e159–e68. [PMC free article: PMC4384819] [PubMed: 25844394]
225.
Stover J, Andreev K, Slaymaker E, Gopalappa C, Sabin K, Velasquez C, et al. Updates to the spectrum model to estimate key HIV indicators for adults and children. AIDS. 2014;28 Suppl 4:S427–34. [PMC free article: PMC4247263] [PubMed: 25406748]
226.
Drummond M, Sculpher M, Torrance G, O'Brien BJ, Stoddart G. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press; 2005.
227.
The costs of HIV testing and counseling services in Botswana. Washington (DC): Futures Group; 2014.
228.
Mulogo EM, Batwala V, Nuwaha F, Aden AS, Baine OS. Cost effectiveness of facility and home based HIV voluntary counseling and testing strategies in rural Uganda. Afr Health Sci. 2013;13(2):423–9. [PMC free article: PMC3824487] [PubMed: 24235945]
229.
Koller M, Patel K, Chi BH, Wools-Kaloustian K, Dicko F, Chokephaibulkit K, et al. Immunodeficiency in children starting antiretroviral therapy in low-, middle-, and high-income countries. J Acquir Immune Defic Syndr. 2015;68(1):62–72. [PMC free article: PMC4351302] [PubMed: 25501345]
230.
Avila D, Althoff KN, Mugglin C, Wools-Kaloustian K, Koller M, Dabis F, et al. Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries. J Acquir Immune Defic Syndr. 2014;65(1):e8–16. [PMC free article: PMC3894575] [PubMed: 24419071]
231.
Short, medium and long term product development priorities in HIV-related diagnostics WHO expert meeting report. Geneva: World Health Organization; 2012. [22 May 2015]. http://www​.who.int/hiv​/pub/meetingreports​/hiv_diagnostics/en/
232.
Pant Pai N, Balram B, Shivkumar S, Martinez-Cajas JL, Claessens C, Lambert G, et al. Head-to-head comparison of accuracy of a rapid point-of-care HIV test with oral versus whole-blood specimens: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(5):373–80. [PubMed: 22277215]
233.
Stekler JD, O'Neal JD, Lane A, Swanson F, Maenza J, Stevens CE, et al. Relative accuracy of serum, whole blood, and oral fluid HIV tests among Seattle men who have sex with men. J Clin Virol. 2013;58 Suppl 1:e119–22. [PMC free article: PMC3867744] [PubMed: 24342471]
234.
O'Connell RJ, Merritt TM, Malia JA, VanCott TC, Dolan MJ, Zahwa H, et al. Performance of the OraQuick rapid antibody test for diagnosis of human immunodeficiency virus type 1 infection in patients with various levels of exposure to highly active antiretroviral therapy. J Clin Microbiol. 2003;41(5):2153–5. [PMC free article: PMC154669] [PubMed: 12734265]
235.
O'Connell RJ, Agan BK, Anderson SA, Malia JA, Michael NL. Sensitivity of the Multispot HIV-1/HIV-2 rapid test using samples from human immunodeficiency virus type 1-positive individuals with various levels of exposure to highly active antiretroviral therapy. J Clin Microbiol. 2006;44(5):1831–3. [PMC free article: PMC1479184] [PubMed: 16672414]
236.
Aghokeng AF, Mpoudi-Ngole E, Dimodi H, Atem-Tambe A, Tongo M, Butel C, et al. Inaccurate diagnosis of HIV-1 group M and O is a key challenge for ongoing universal access to antiretroviral treatment and HIV prevention in Cameroon. PLoS One. 2009;4(11):e7702. [PMC free article: PMC2768789] [PubMed: 19893738]
237.
Klarkowski D, O'Brien DP, Shanks L, Singh KP. Causes of false-positive HIV rapid diagnostic test results. Expert Rev Anti Infect Ther. 2014;12(1):49–62. [PubMed: 24404993]
238.
Klarkowski D, Glass K, O'Brien D, Lokuge K, Piriou E, Shanks L. Variation in specificity of HIV rapid diagnostic tests over place and time: an analysis of discordancy data using a Bayesian approach. PLoS One. 2013;8(11):e81656. [PMC free article: PMC3840056] [PubMed: 24282615]
239.
Doran TI, Parra E. False-positive and indeterminate human immunodeficiency virus test results in pregnant women. Arch Fam Med. 2000;9(9):924–9. [PubMed: 11031402]
240.
Gasasira AF, Dorsey G, Kamya MR, Havlir D, Kiggundu M, Rosenthal PJ, et al. False-positive results of enzyme immunoassays for human immunodeficiency virus in patients with uncomplicated malaria. J Clin Microbiol. 2006;44(8):3021–4. [PMC free article: PMC1594619] [PubMed: 16891532]
241.
Lejon V, Ngoyi DM, Ilunga M, Beelaert G, Maes I, Buscher P, et al. Low specificities of HIV diagnostic tests caused by Trypanosoma brucei gambiense sleeping sickness. J Clin Microbiol. 2010;48(8):2836–9. [PMC free article: PMC2916589] [PubMed: 20573878]
242.
Sands A, Vercauteren G, Fransen K, Beelaert G. Poor antigen sensitivity of three innovative rapid diagnostic tests (RDTs) for detection of HIV-1 p24 antigen and HIV-1/2 antibodies; Paper presented at: 19th International AIDS Conference; 2012 July 22-27; Washington (DC), USA.
243.
Taegtmeyer M, MacPherson P, Jones K, Hopkins M, Moorcroft J, Lalloo DG, Chawla A. Programmatic evaluation of a combined antigen and antibody test for rapid HIV diagnosis in a community and sexual health clinic screening programme. PLoS One. 2011;6(11):e28019. [PMC free article: PMC3222669] [PubMed: 22132195]
244.
Conway DP, Holt M, McNulty A, Couldwell DL, Smith DE, Davies SC, et al. Multi-centre evaluation of the Determine HIV Combo assay when used for point of care testing in a high risk clinic-based population. PLoS One. 2014;9(4):e94062. [PMC free article: PMC3979750] [PubMed: 24714441]
245.
Duong YT, Mavengere Y, Patel H, Moore C, Manjengwa J, Sibandze D, et al. Poor performance of the determine HIV-1/2 Ag/Ab combo fourth-generation rapid test for detection of acute infections in a national household survey in Swaziland. J Clin Microbiol. 2014;52(10):3743–8. [PMC free article: PMC4187782] [PubMed: 25122853]
246.
Sherman GG, Lilian RR, Coovadia AH. The performance of 5 rapid HIV tests using whole blood in infants and children: selecting a test to achieve the clinical objective. Pediatr Infect Dis J. 2012;31(3):267–72. [PubMed: 22031486]
247.
Pinowar-Manning E, James M, Johnson-Lewis L, Sun J, Hoover D, Richardson P, et al. Evaluation of a rapid point-of-care test to screen for HIV infection in infants; Paper presented at: 19th International AIDS Conference; 2012 July 22-27; Washington, DC, USA.
248.
Tchounga B, Inwoley A, Coffie P, Minta D, Messou E, Bado G, et al. Re-testing and misclassification of HIV-2 and HIV-1&2 dually reactive patients among the HIV-2 cohort of The West African Database to evaluate AIDS collaboration. J Int AIDS Soc. 2014;17(1):19064. [PMC free article: PMC4134669] [PubMed: 25128907]
249.
Singh L, Parboosing R, Manasa J, Moodley P, de Oliveira T. High level of HIV-2 false positivity in KwaZulu-Natal province: a region of South Africa with a very high HIV-1 subtype C prevalence. J Med Virol. 2013;85(12):2065–71. [PubMed: 23959597]
250.
HIV assays: laboratory performance and other operational characteristics: rapid diagnostic tests (combined detection of HIV-1/2 antibodies and discriminatory detection of HIV-1 and HIV-2 antibodies): report 18. Geneva: World Health Organization; 2015. [30 March 2015]. http://www​.who.int/diagnostics​_laboratory​/publications/15032_hiv_assay_report18​.pdf?ua=1.
251.
Revised recommendations for the selection and use of HIV antibody tests. Geneva: World Health Organization; 1997. [3 March 2015]. http://www​.who.int/diagnostics​_laboratory​/publications/en/Selection_HIV_tests​.pdf.
252.
Gray R, Makumbi F, Serwadda D, Lutalo T, Nalugoda F, Opendi P, et al. Limitations of rapid HIV-1 tests during screening for trials in Uganda: diagnostic test accuracy study. BMJ. 2007;335(7612):188. [PMC free article: PMC1934458] [PubMed: 17545184]
253.
da Costa Ferreira, Junior O, Ferreira C, Riedel M, Visinoni W, Sasazawa I, Westman S, et al. Field evaluation of an HIV rapid test algorithm for the rapid diagnosis of HIV infection in Brazil; Paper presented at: 4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention;; 2007 July 22-25; Sydney, Australia.
254.
Boeras D, Luisi N, Karita E, McKinney S, Sharkey T, Keeling M, et al. Indeterminate and discrepant rapid HIV test results in couples' HIV testing and counselling centres in Africa. J Int AIDS Soc. 2011;14(18):14–8. [PMC free article: PMC3086828] [PubMed: 21477317]
255.
Crucitti T, Taylor D, Beelaert G, Fransen K, Van Damme L. Performance of a rapid and simple HIV testing algorithm in a multicenter phase III microbicide clinical trial. Clin Vaccine Immunol. 2011;18(9):1480–5. [PMC free article: PMC3165239] [PubMed: 21752945]
256.
Baveewo S, Kamya MR, Mayanja-Kizza H, Fatch R, Bangsberg DR, Coates T, et al. Potential for false positive HIV test results with the serial rapid HIV testing algorithm. BMC Res Notes. 2012;5:154. [PMC free article: PMC3392728] [PubMed: 22429706]
257.
Fogel JM, Piwowar-Manning E, Donohue K, Cummings V, Marzinke MA, Clarke W, et al. Determination of HIV status in African adults with discordant HIV rapid tests. J Acquir Immune Defic Syndr. 2015 [PMC free article: PMC4483143] [PubMed: 25835607]
258.
Shanks L, Siddiqui MR, Kliescikova J, Pearce N, Ariti C, Muluneh L, et al. Evaluation of HIV testing algorithms in Ethiopia: the role of the tie-breaker algorithm and weakly reacting test lines in contributing to a high rate of false positive HIV diagnoses. BMC Infect Dis. 2015;15(1):39. [PMC free article: PMC4331460] [PubMed: 25645240]
259.
Sato P, Maskill W, Tamashiro H, Heymann D. Strategies for laboratory HIV testing: an examination of alternative approaches not requiring Western blot. Bull World Health Org. 1994;72(1):129–34. [PMC free article: PMC2486505] [PubMed: 8131248]
260.
Brattegaard K, Kouadio J, Adom M, Doorly R, George J, De Cock K. Rapid and simple screening and supplemental testing for HIV-1 and HIV-2 infections in West Africa. AIDS. 1993;7(6):883–5. [PubMed: 8395857]
261.
Klarkowski DB, Wazome JM, Lokuge KM, Shanks L, Mills CF, O'Brien DP. The evaluation of a rapid in situ HIV confirmation test in a programme with a high failure rate of the WHO HIV two-test diagnostic algorithm. PLoS One. 2009;4(2) [PMC free article: PMC2633037] [PubMed: 19197370]
262.
WHO reminds national programmes to retest all newly diagnosed people with HIV. WHO information note – 22 October 2014. Geneva: World Health Organization; 2014. [22 May 2015]. http://www​.who.int/hiv​/pub/vct/retest-newly-diagnosed-plhiv-full/en/
263.
Guidelines for assuring the accuracy and reliability of HIV rapid testing: applying a quality system approach. Geneva: World Health Organization; 2005. [7 June 2015]. http://www​.who.int/diagnostics​_laboratory​/publications/HIVRapidsGuide.pdf.
264.
Quality assurance resource pack for voluntary counselling and testing service providers. Nairobi: Liverpool VCT and Care, Kenya; 2003. [3 March 2015]. http://www​.who.int/hiv​/topics/vct/toolkit​/components/training/en/index1.html.
265.
Overview of the prequalification of in vitro diagnostics assessment. Geneva: World Health Organization; 2014. [29 March 2015]. http://www​.who.int/diagnostics​_laboratory​/evaluations/140530​_pqdx_overview_doc_007.pdf.
266.
Laboratory quality management system: handbook. Geneva: World Health Organization; 2011. [22 May 2015]. http://www​.who.int/ihr​/publications/lqms/en/
267.
Guidelines for using HIV testing technologies in surveillance: selection, evaluation and implementation – 2009 update. Geneva: World Health Organization, Joint United Nations Programme on HIV/AIDS; 2009. [30 June 2015]. http://apps​.who.int/iris​/bitstream/10665​/164358/1/9789241598057_eng.pdf?ua=1. [PubMed: 26203489]
268.
Baggaley R, Johnson C, Garcia J, Sabin K, Zaba B, Obermeyer C, et al. Routine feedback of test results to participants in clinic- and survey-based surveillance of HIV. Bull World Health Organ. 2015 [PMC free article: PMC4431522] [PubMed: 26229207]
269.
Maher D. The ethics of feedback of HIV test results in population-based surveys of HIV infection. Bull World Health Org. 2013;91(12):950–6. [PMC free article: PMC3845269] [PubMed: 24347734]
270.
Rennie S, Turner AN, Mupenda B, Behets F. Conducting unlinked anonymous HIV surveillance in developing countries: ethical, epidemiological and public health concerns. PLoS Med. 2009;6(1) [PMC free article: PMC2628398] [PubMed: 19166264]
271.
Guidelines for conducting HIV sentinel serosurveys among pregnant women and other groups. Geneva: World Health Organization, Joint United Nations Programme on HIV/AIDS; 2003. [1 March 2015]. http://data​.unaids.org​/Publications/IRC-pub06​/JC954-ANC-Serosurveys​_Guidelines_en.pdf.
272.
Guidelines for measuring national HIV prevalence in population-based surveys. Geneva: World Health Organization, Joint United Nations Programme on HIV/AIDS; 2005. [16 March 2015]. http://www​.who.int/hiv​/pub/surveillance/measuring/en/
273.
Guidelines on surveillance among populations most at risk for HIV. Geneva: World Health Organization, Joint United Nations Programme on HIV/AIDS; 2011. [21 April 2015]. http://www​.who.int/hiv​/pub/surveillance/most_at_risk/en/
274.
Guidelines for second generation HIV surveillance: an update: know your epidemic. Geneva: World Health Organization, Joint United Nations Programme on HIV/AIDS; 2013. [10 March 2015]. http://apps​.who.int/iris​/bitstream/10665​/85511/1/9789241505826_eng.pdf?ua=1. [PubMed: 24049865]
275.
Making the case with strategic information: young key populations at higher risk of HIV in Asia and the Pacific. Bangkok: United Nations Children's Fund; 2013. [8 March 2015]. http://www​.unicef.org​/eapro/Young_key_populations​_at_high_risk​_of_HIV_in_Asia_Pacific.pdf.
276.
Guiding principles on ethical issues in HIV surveillance. Geneva: World Health Organization, Joint United Nations Programme on HIV/AIDS; 2013. [11 March 2015]. http://apps​.who.int/iris​/bitstream/10665​/90448/1/9789241505598_eng.pdf.
277.
Tool for setting and monitoring targets for HIV prevention and diagnosis, treatment and care for key populations. Geneva: World Health Organization; (in press)
278.
WHO policy on collaborative TB/HIV activities: guidelines for national programmes and other stakeholders. Geneva: World Health Organization; 2012. [5 March 2015]. http://www​.who.int/tb​/publications/2012/tb​_hiv_policy_9789241503006/en/ [PubMed: 23586124]
279.
Guidelines for sexually transmitted infections surveillance. Geneva: World Health Organization, Joint United Nations Programme on HIV/AIDS; 1999. [10 March 2015]. http://www​.who.int/hiv​/pub/sti/pubstiguidelines/en/
280.
Guidelines for the management of sexually transmitted infections. Geneva: World Health Organization; 2003. [2 March 2015]. http://www​.who.int/hiv/pub/sti/pub6/en/
281.
WHO-recommended standards for surveillance of selected vaccine-preventable diseases. Geneva: World Health Organization; 2003. [22 April 2015]. http://whqlibdoc​.who​.int/hq/2003/who_v&b_03.01.pdf.
282.
Guidance on prevention of hepatitis B and hepatitis C among people who inject drugs. Geneva: World Health Organization; 2015. [29 March 2015]. http://www​.who.int/hiv​/pub/guidelines/hepatitis/en/
283.
Guidelines for HIV surveillance among tuberculosis patients. Geneva: World Health Organization, Joint United Nations Programme on HIV/AIDS; 2004. [3 March 2015]. http://www​.who.int/hiv​/pub/tb/guidelines/en/
284.
Guidelines for the screening, care and treatment of persons with hepatitis C infection. Geneva: World Health Organization; 2014. [24 March 2015]. http://apps​.who.int/iris​/bitstream/10665​/111747/1/9789241548755_eng.pdf?ua=1. [PubMed: 25535634]
285.
Consultative meeting on HIV testing in the context of HIV surveillance. Geneva: World Health Organization, Joint United Nations Programme on HIV/AIDS; 2014.
286.
When and how to use assays for recent infection to estimate HIV incidence at a population level. Geneva: World Health Organization, Joint United Nations Programme on HIV/AIDS; 2011. [22 May 2015]. http://www​.who.int/hiv​/pub/surveillance/sti_surveillance/en/
287.
WHO/UNAIDS annual meeting of the Technical Working Group on HIV Incidence Assays. Geneva: World Health Organization, Joint United Nations Programme on HIV/AIDS; 2014. [22 May 2015]. http://www​.who.int/hiv​/pub/meetingreports​/twg-hiv-incidence-assays/en/
288.
Technical update on HIV incidence assays for surveillance and monitoring purposes. Geneva: Joint United Nations Programme on HIV/AIDS, World Health Organization; 2015. [1 April 2015]. http://www​.unaids.org​/sites/default/files​/media_asset/HIVincidenceassayssurveillancemonitoring_en​.pdf.
289.
Guidelines for conducting HIV surveillance among pregnant women attending antenatal clinics based on routine prevention of mother-to-child transmission of HIV (PMTCT) programme data. Geneva: World Health Organization, Joint United Nations Programme on HIV/AIDS; 2015. [22 May 2015]. http://apps​.who.int/iris​/bitstream/10665​/85512/1/9789241505611_eng.pdf.
290.
Considerations and guidance for countries adopting national health identifiers. Geneva: Joint United Nations Programme on HIV/AIDS; 2014. [4 June 2015]. http://www​.unaids.org​/sites/default/files​/media_asset/JC2640​_nationalhealthidentifiers_en.pdf.
291.
Mortimer JY, Salathiel JA. ‘Soundex’ codes of surnames provide confidentiality and accuracy in a national HIV database. Commun Dis Rep CDR Rev. 1995;5(12):R183–6. [PubMed: 8541940]
292.
WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. Geneva: World Health Organization; 2006. [22 May 2015]. http://www​.who.int/hiv​/pub/guidelines/hivstaging/en/
293.
Surveillance of HIV infection using case notification Recommendations for improving and strengthening HIV surveillance systems. Geneva: World Health Organization, Joint United Nations Programme on HIV/AIDS; 2011. [1 April 2015]. http://apps​.who.int/iris​/bitstream/10665​/90893/1/9789241506298_eng.pdf.
Copyright © World Health Organization 2015.

All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: tni.ohw@sredrokoob).

Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution– should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html).

Bookshelf ID: NBK316015

Views

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...